NM-2201, also known as CBL-2201, is an indole-based synthetic cannabinoid that acts as a full agonist, unselectively binding to CB1 and CB2 receptors with low nanomolar affinity. It is structurally similar to AM-2201, differing by an ester linking the 3' position to the naphthyl group. The physiological and toxicological properties of NM-2201 are not well characterized due to limited research data. NM-2201 was discovered by Alexandros Makriyannis from Northeastern University and is regulated as a Schedule I compound in the United States. It is intended for forensic and research applications. Usage: Used in Forensic Applications: NM-2201 is used as a forensic tool for the detection and analysis of synthetic cannabinoids in various samples, such as blood, urine, and hair. This helps in identifying the presence of the compound in cases of drug abuse or intoxication. Used in Research Applications: NM-2201 serves as a research compound for studying the effects and mechanisms of action of synthetic cannabinoids on CB1 and CB2 receptors. This can contribute to a better understanding of the endocannabinoid system and the development of potential therapeutic agents targeting these receptors. Used in Pharmaceutical Development: Although the physiological actions of NM-2201 have not been fully characterized, it may be used in the development of new pharmaceuticals targeting the endocannabinoid system. This could potentially lead to the discovery of novel treatments for various medical conditions, pending further research and characterization of its properties.
The CAS Registry Mumber 837112-21-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,7,1,1 and 2 respectively; the second part has 2 digits, 2 and 1 respectively. Calculate Digit Verification of CAS Registry Number 837112-21: (8*8)+(7*3)+(6*7)+(5*1)+(4*1)+(3*2)+(2*2)+(1*1)=147 147 % 10 = 7 So 837112-21-7 is a valid CAS Registry Number.